Ticari markalar

OPDIVO^® (nivolumab) – Bristol-Myers Squibb Company

YERVOY^® (ipilimumab) – Bristol-Myers Squibb Company

REBLOZYL^® (luspatersept) – Bristol-Myers Squibb Company

SPRYCEL^® (dasatinib) – Bristol-Myers Squibb Company

BARACLUDE^® (entekavir) – Bristol-Myers Squibb Company

ORENCIA^® (abatasept) – Bristol-Myers Squibb Company

INREBIC^® (fedratinib) – Bristol-Myers Squibb Company

ONUREG^® (azasitidin) – Bristol-Myers Squibb Company

ZEPOSIA^® (ozanimod) – Bristol-Myers Squibb Company

NO-TR-2400051-09/2024